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Current techniques for assessment of upper
extremity vasculature prior to hemodialysis
vascular access creation
Abstract Vascular access problems
lead to increased patient morbidity
and mortality and place a large burden
on care facilities, manpower and costs.
Autogenous arteriovenous fistulas
(AVF) are preferred over arteriove-
nous grafts (AVG) because of a lower
incidence of vascular access related
complications. An aggressive increase
in the utilization of AVF, however,
results in an increased incidence of
AVF early failure and non-maturation.
Increasing evidence suggests that
routine preoperative assessment re-
sults in an increased utilization of
functioning AVF by better selection of
adequate vessels. To date, the repro-
ducibility and standardization of as-
sessment protocols are lacking and
assessment of a single morphological
parameter has not enabled adequate
prediction of postoperative AVF
function for individual patients. In this
paper, we provide an overview of
available diagnostic modalities and
parameters that potentially enable
better selection of adequate vessels for
successful AVF creation.
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Introduction
End-stage renal disease (ESRD), defined as complete or
near complete renal failure, is an increasingly important
medical problem, ultimately requiring hemodialysis in the
vast majority of patients. The incidence and prevalence of
ESRD as well as the number of patients requiring
hemodialysis have sharply risen over the past few years.
In 2004, an estimated 1.22-million patients were on
hemodialysis world-wide, representing a 20% increase in
3 years since 2001 [1, 2].
A well-functioning vascular access is the cornerstone of
hemodialysis treatment and can be achieved by insertion of
a central venous catheter or by surgical creation of an
arteriovenous fistula or graft (Fig. 1). The access of first
choice is the autogenous arteriovenous fistula (AVF)
because of its better long-term performance and patency
rates when compared with arteriovenous grafts (AVG) and
central venous catheters (CVC). Furthermore, AVFs have
lower vascular access related morbidity, mortality and
healthcare costs compared with AVG and CVC [3, 4]. In
contrast, prosthetic vascular grafts require about five-times
more therapeutic interventions compared with AVF to keep
the access functioning [5–7].
In order to reduce long-term vascular access related
complications, the Dialysis Outcome Quality Initiative (K-
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DOQI) and Good Nephrological Practice guidelines
advocate an all AVF policy, i.e. at least 70% of all newly
created accesses should consist of autogenous AVF [3, 4].
However, the major drawback of AVF creation is the
relatively high frequency of early thrombosis—up to 10–
20% of all newly created vascular accesses thrombose
within the first week after creation—and non-maturation
[8, 9]. Non-maturation is defined as an AVF being
inadequate for hemodialysis due to insufficient flow-
volume or insufficient venous distension after creation.
Causes of non-maturation are thought to be the use of tiny
vessels in addition to arterial inflow or venous outflow
stenoses or occlusions [9–13]. Furthermore, the presence of
large caliber side branches may also jeopardize AVF
maturation due to a disadvantageous flow distribution [3,
14, 15]. Different studies have reported AVF non-matura-
tion rates within the first months after creation from 5% up
to 54% [12, 16–20].
In order to increase the number of mature and functional
AVFs, adequate history taking, physical examination and
preoperative assessment of upper extremity vessels is
important [3, 4, 19]. Increasingly, arterial and venous
diameters as well as the presence and location of
preexisting atherosclerotic occlusive disease and venous
stenoses, occlusions and side-branches are used to guide
the choice of fistula type and location. Consequently,
interest has risen in preoperative imaging of upper
extremity vessels. The goal of preoperative imaging is
assessment of vessel caliber and identification of sites
where arteries and veins are of suboptimal quality for
access purposes.
The current review will provide the radiologist with an
overview of the clinical role and relative merits and
shortcomings of physical examination, duplex ultrasonog-
raphy (DUS), digital subtraction angiography (DSA) and
contrast-enhanced magnetic resonance angiography (CE-
MRA) in the preoperative work-up of patients awaiting
surgical creation of a vascular access for hemodialysis.
History taking and physical examination
The cornerstone of any pre-surgical workup is a thorough
history and physical examination. Negroid race, female
gender, diabetes mellitus, peripheral arterial occlusive
disease, previous vascular access procedures and axillary
radiation therapy are associated with poor vascular access
outcome [4].
Careful physical examination is important in the work-
up of patients awaiting vascular access surgery. Skin
lesions, local infections, generalized dermatological prob-
lems and scars, in addition to small arterial caliber and lack
of pulse vigorousness as well as small venous caliber and
distensibility, may indicate poor chance of successful AVF
creation at standard locations and should therefore be
documented and addressed [4]. However, arterial and
venous assessment by physical examination can be
challenging and of limited value in obese patients [12,
21]. Malovrh et al. [9] found that physical examination
failed to identify suitable vessels for AVF creation in over
half of all patients undergoing dialysis access surgery (n=
62/116; 54%), underscoring the need for additional
information prior to access creation.
Duplex ultrasonography
DUS enables assessment of vessel patency, diameter, flow-
volume and velocities. The application of DUS enables
better depiction of adequate vessels for AVF creation that
may not be detected by physical examination, especially in
obese patients [9, 12, 21, 22]. Multiple studies have found
that the application of DUS resulted in changes in surgical
procedure in 31% of cases, changes in site of exploration
(9.6%), a decrease in unsuccessful explorations (11% to
0%), an increase in the relative number of AVFs created (as
opposed to other types of access; 64% vs 34%), and a
decrease in non-maturation rates (38% to 8.3% and 66% to
46%), when compared with the use of physical examina-
tion alone [12, 16, 23–25]. However, reported cut-off
Fig. 1 Schematic overview of a radial-cephalic arteriovenous wrist
fistula (left) and a forearm arteriovenous loop graft (right). The graft
anastomosed to the brachial artery and cephalic vein at the
antecubital crease in an end (graft) to side (vessel) fashion. The
loop has been tunneled underneath the skin to enable easy
cannulation
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values of various DUS-derived parameters (i.e. diameter,
flow-volume, velocities, compliance and resistive index)
are inconsistent. An aggressive approach to conform to the
all AVF policy may, therefore, still result in increased early
failure and non-maturation rates if based on a single DUS-
derived parameter [26, 27]. It remains to be established if a
combination of parameters might enable better prediction
of vascular access function and minimize early failure and
non-maturation rates.
Arterial assessment
Preoperative DUS examination should include assessment
of the arteries from the subclavian artery down to the radial
and ulnar arteries at the wrist [4]. The exact course and
continuity as well as the presence of stenoses should be
addressed because patients with arterial stenosis are
thought to be at increased risk for developing hand and
finger ischemia after AVF creation due to steal phenomena
[4]. For detection of relevant stenoses (defined as >50%
luminal reduction) in the upper extremity arterial system,
DUS has a sensitivity and specificity of 90.9% and 100%
for the subclavian artery, 93.3% and 100% for upper arm
arteries, 88.6% and 98.7% for forearm arteries and for the
arteries of the hand 70% and 100%, respectively [28, 29].
Another important morphological parameter apart from
the presence of arterial stenosis is arterial diameter. Arteries
with diameters smaller than 1.5 to 3.0 mm have been
associated with increased non-maturation rates AVF [11,
24, 25, 30–33].
Additional parameters such as radial artery flow volume
and peak systolic velocities before or during reactive
hyperemia have also been reported to be predictors of AVF
maturation. In Fig. 2, radial artery flow velocity changes
due to fist clenching and reactive hyperemia are shown.
Lockhart et al. [27], in contrast, found that arterial
diameters, resistance indices and peak systolic velocities
had only little if any predictive value for AVF outcome.
Venous assessment
The superficial venous system of the upper extremity is
easily assessable by DUS and results in detection of more
veins compared with physical examination alone [12, 21,
22]. Furthermore, it also allows for assessment of local
hemodynamics, such as subclavian vein flow. A typical
example of Doppler signal changes of the subclavian vein
during deep inspiration in a healthy volunteer is shown in
Fig. 3. The absence of changes in venous Doppler signal
due to deep inspiration or loss of venous compressibility is
another important finding indicative for local venous
stenosis or occlusion. Preoperative detection of stenoses
Fig. 2 Duplex ultrasound assessment of radial artery flows at rest
(a), during fist clenching (b) and during hyperemia after the fist
clench has been released in a healthy volunteer. The arrow indicates
the moment of fist clench release. Absence or diminished change in
radial artery flow is associated with a higher risk of vascular access
early failure and non-maturation
Fig. 3 The effect of deep inspiration on subclavian vein flow
assessed with duplex ultrasound. The arrow indicates the start of
deep inspiration. Absence or diminished subclavian vein flow or
change flow due to deep inspiration is indicated for central venous
stenosis or occlusion
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and obstructions is important to avoid unsuccessful
surgical explorations [4]. Nack et al. [34] reported a DUS
sensitivity, specificity, positive predictive value and neg-
ative predictive value of 81%, 90%, 90% and 78%
respectively, for detection of venous stenosis, thrombi
and occlusions when compared with DSA.
The clinical value of upper extremity DUS for detection
of arterial or venous abnormalities is lower for proximal
compared with distal arteries or veins, respectively. For
instance, Nack et al. [34] reported progressive decreasing
DUS sensitivities for detection of abnormalities in the
subclavian vein (79%), innominate vein (75%), and
superior vena cava (33%), when compared with DSA.
This can be explained by the fact that veins course
underneath bony structures such as the clavicle and ribs
over a substantial length and because the central thoracic
veins are relatively inaccessible by DUS because of the
distance to the transducer.
As is the case for arteries, DUS-derived venous diameter
is an important parameter for prediction of vascular access
outcome. For assessment of venous diameter, a proximally
applied cuff should be used to induce venous dilatation for
better appreciation of ‘maximum’ or ‘true’ venous diameter
[3, 4]. Reported venous cut-off diameters for successful
AVF creation range from 1.6 to 2.6 mm [9, 19, 24, 25, 30,
33, 35]. This range may be partially explained by differ-
ences in vein mapping protocols because only few authors
reported the measurement conditions and methods to
achieve venous dilatation. Furthermore, DUS venous
diameter measurements are observer-dependent with an
inter-observer variation of 0.5 mm [36]. Recently, Planken
et al. [37] have demonstrated that superficial forearm vein
diameter measurements vary over time with a coefficient of
variation of 27%. In addition, forearm superficial venous
diameter measurement reproducibility depends on the
applied venous congestion pressure and best reproducibility
is achieved at venous congestion pressures >40mmHg [38].
Preoperative contiguous length of non-diseased vein >10 cm
in addition to venous diameter was predictive for the AVF
function [31, 39].
Apart from venous diameter, some authors have found an
association between the presence and size of venous side
branches andAVF non-maturation.Wong et al. [33] suggested
that a side branch <5 cm away from the planned anastomosis
may impair AVF function, whereas Beathard et al. [15] have
stressed the importance of the size of the venous side branches.
In the aforementioned studies non-maturation wasmore likely
in the event of a large venous side branch. Turmel-Rodrigues
et al. [14], in contrast, state that venous side branches are of no
importance and only come into play in the presence of a
venous outflow stenosis.
Dynamic parameters to characterize upper extremity
veins include flow volume and velocity measurements as
well as assessment of flow wave changes due to respiratory
maneuvers [4]. The capacity of superficial veins to dilate
due to venous congestion (also known as compliance) has
been reported to be higher within a group of patients in
whom AVF creation was successful compared with patients
with AVF that failed to mature (diameter increase 48%
versus 11.8% at a congestion pressure of 50 mmHg) [9].
Forearm superficial venous compliance measurements,
however, have been reported to be poorly reproducible due
to poor reproducibility of venous diameters at low venous
congestion pressures [38]. The clinical value of forearm
superficial venous compliance measurements is therefore
considered of little if any use.
Digital subtraction angiography
Digital subtraction angiography (DSA), using X-ray tech-
niques and iodinated contrast-media is considered the standard
of reference for assessment of upper extremity arteries and
Fig. 4 Example of venograms
obtained in a single patient by
CO2 venography (a) and by
conventional venography using
iodinated contrast media (b).
(Images were kindly provided
by Dr. S. Heye, from the




veins. A drawback, however, is that acquired data are two-
dimensional (2D) projections and analysis is limited by the
number and quality of the acquired projections. Furthermore,
the clinical applicability in the work-up of ESRD patients is
limited due to the use of iodinated nephrotoxic contrast-media
that may lead to temporary or permanent deterioration of
residual renal function in up to 20% of the cases [40]. Further
deterioration of renal function should be avoided because loss
of residual renal function is associated with higher morbidity
andmortality rates [41, 42]. Another important reason to avoid
the use of iodinated contrast media is the chance of renal
function recovery, even after initiation of hemodialysis
therapy. In addition, residual kidney functions such as
secretion of organic acids and various endocrine functions
cannot be provided by dialysis and should therefore be
preserved as long as possible [41]. An additional obvious
drawback of DSA is the invasive nature of the examination,
especially for the depiction of the arterial system.
Geoffroy et al. [40] reported on the safety and clinical
performance of IA-DSA using gadolinium chelates in ESRD
patients and concluded that they were well tolerated with
minimal impairment of renal function (mean 3%, <12% in all
cases). However, others reported serious complications
associated with the off-label use of available gadolinium
chelates at doses exceeding 0.3 mmol/kg [43–46]. The high
osmolality of contrast media is a pathogenetic factor in
contrast induced nephropathy (CIN) that potentially leads to
further renal function impairment. CIN is more likely in
patients with pre-existing impaired renal function [43, 44, 46,
47]. Gadolinium chelates are hypertonic and the osmolality of
commercially available gadolinium chelates is two- to seven-
times that of plasma [43, 46]. To prevent CIN due to
hypertonicity the dose should not exceed 0.3 mmol/kg. Older
patients and patients with lower baseline creatinine clearance,
diabetic nephropathy and low haemoglobin and albumin
levels are at increased risk for developing gadolinium induced
CIN, with a reported incidence between 0 and 11% [40, 47].
Fig. 5 Two consecutive images obtained by digital subtraction
angiography of a central venous obstruction (arrow) due to
pacemaker wires. Arrowheads point at collateral draining veins
Fig. 6 Two consecutive images obtained by digital subtraction
angiography of a central venous obstruction (arrow) due to central
venous catheter use. Arrowheads point at collateral draining veins
3005
Another alternative to iodinated contrast-media and
gadolinium chelates is carbon dioxide (CO2) gas injection
[40]. In a recent report Heye et. al. [48] demonstrated that
CO2 venography is an acceptable alternative (sensitivity,
97%; specificity, 85%; accuracy, 95%) for assessment of
upper-extremity and central veins in patients with contra-
indications to conventional venography with iodinated
contrast material. In Fig. 4, a CO2 venogram and
corresponding conventional venogram are shown. How-
ever, CO2 injections may cause pain and the CO2 contrast
technique can lead to stenosis grade overestimation [40].
The use of CO2 contrast may furthermore lead to serious
complications, such as brain gas embolism, pulmonary
embolism or acute cardiac arrest [40].
Arterial assessment
Upper extremity arteriography is traditionally performed by
intra-arterial injection of contrast-media. Arterial access can
be achieved by femoral or brachial puncture. In patients with
ESRD the brachial artery approach is generally avoided
because it can be painful, it may jeopardize distal perfusion
and thereby maturation and function of a vascular access
created distal to the puncture site. Thrombosis of the brachial
artery is a serious complication due to brachial punctures for
catheter access in up to 7% [49–51]. Contralateral venous
injection of contrast media is a less invasive alternative with
fewer complications. However, in order to achieve sufficient
arterial enhancement, this technique requires a high contrast
dose which is unacceptable in ESRD patients due to the
potential further deterioration of residual renal function.
Venous assessment
Central venous stenosis and obstruction occur frequently
after central venous catheter insertion or placement of
pacemaker wires, however, often patients remain asymp-
tomatic. Imaging of the subclavian—innominate—and
superior caval veins prior to vascular access creation is
important because 40% of patients with a history of central
venous catheters have central venous stenosis or obstruc-
tion [52]. Examples of central venous obstructions due to
pacemaker wires and central venous catheter use are shown
in Figs. 5 and 6.
Venography by cannulation of an ipsilateral dorsal hand
vein allows imaging of the entire cephalic or basilic veins from
the hand up to the confluence of the basilic and brachial veins
into the subclavian vein. Although the superficial veins of the
upper extremity are connected to each other at multiple levels,
the puncture site will limit venous opacification to the draining
vein of the puncture site only. It is important to avoid
puncturing veins proximal to the distal radius in order to
preserve draining veins for future access use. In our experi-
ence, the use of a proximal tourniquet inflated to 60 mmHg
enables depiction of collateral veins and improves assessment
of venous diameter because of dilatation. Good inter-observer
correlation coefficients have been reported for assessment of
venous quality prior to access creation using conventional X-
ray venography techniques and gadolinium chelates as
contrast media (kappa values, cephalic vein: forearm 0.65,
arm 0.88; basilic vein: forearm 0.72; arm 0.64). Opacification
of upper extremity veins is generally adequate although
opacification of central veins can remain problematic, even
after administration of increased contrast volumes [40].
Fig. 7 Example of selective
CE-MRA of upper extremity
arteries (a) and veins (b), by
contralateral and ipsipateral in-
jection of contrast media, re-
spectively. Images of the entire
upper extremity vasculature
were acquired in four consecu-
tive phases. First distal arteries
(forearm), second proximal ar-
teries (upper arm and thorax),
third proximal veins (upper arm
and thorax) and fourth distal
veins (forearm). (sa subclavian
artery, ba brachial artery, ra
radial artery, ua ulnar artery, sv
subclavian vein, cv cephalic
vein, bv basilic vein)
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Magnetic resonance angiography (MRA)
Ongoing technical improvements have made MRA an
important and valuable imaging modality in recent years in
the preoperative workup of patients with ESRD. With the
introduction of contrast-enhanced MRA techniques, the
role of non-enhanced time-of-flight (TOF) MRA has
declined as it is prone to artifacts and stenoses are
frequently overestimated [53]. Because of this reason, we
only discuss contrast-enhanced MRA (CE-MRA).
CE-MRA protocols enable image acquisition with high
spatial (sub-millimeter voxel-size) and temporal resolu-
tions (<20 s per dynamic scan) with good to excellent
image quality [54, 55]. For arterial imaging 0.2–0.3 mmol/
kg 0.5 M extracellular gadolinium chelate contrast medium
is injected in a contralateral antecubital or dorsal hand vein.
For venous imaging diluted (1:15) contrast media is
injected in an ipsilateral dorsal hand vein.
Because intra-thoracic vessels are prone to movement
during respiration, patients should hold their breath for
about 15–20 s depending on scan protocol and technical
factors related to system performance. Contrast medium is
injected at speeds up to 3.0 ml/s, followed by 25 ml of
saline flush. Spatial resolution in recent reports is typically
in the order of 1.0×1.0×1.2 mm3 (cranio-caudal/frequency
direction×left-right/phase-encoding directions×antero-pos-
terior/slice direction) [54]. Using this approach for imag-
ing, upper extremity arteries and veins can be visualized
with high accuracy [54]. Because the average upper
extremity length of an adult is about 70–80 cm, depicting
the entire upper extremity requires imaging of at least two
fields-of-view because of the limited MR-bore length. An
example of a preoperative CE-MR arteriogram and veno-
gram of an ESRD-patient is shown in Fig. 7.
Synchronization of peak arterial or venous contrast
concentration with sampling of central k-space profiles is
very important in order to obtain selective imaging of
arteries or veins, respectively [56]. This is typically done by
performing a timing sequence with 1–2 ml contrast medium
prior to the contrast-enhanced acquisition, or by the use of
real-time bolus monitoring software. In order to improve
both spatial and temporal resolution multi-element surface
coils can be used to enable parallel imaging techniques [57].
Apart from their parallel imaging capabilities these coils
greatly improve vessel-to-background contrast.
Arterial assessment
Planken et al. [54] reported a multi-phase approach using
multiple dynamic scans that resulted in good to excellent
subjective image quality images of upper extremity arteries
down to the wrist. Assessment of the arterial palmar arch
and digital arteries remains cumbersome, however, with the
currently acquired spatial resolutions, except when using
timed arterial compression [55]. An important advance in
this regard is the recent clinical introduction of blood pool
contrast media which enables ultra-high spatial resolution
scans for assessment of the palmar arch and digital arteries
(Fig. 8) [58].
Although CE-MRA is believed to be highly accurate for
detection of arterial stenoses and obstructions there are no
studies about the accuracy and reproducibility for detection
of thoracic and upper extremity arterial stenoses in ESRD
patients. A typical example of a subclavian artery stenosis
depicted by both CE-MRA and DSA is shown in Fig. 9.
Venous assessment
Reported CE-MR venography techniques use either direct
injection of diluted contrast-media (1:15 to 1:25 ml of
gadolinium chelate in saline solution) in the ipsilateral
extremity or contralateral intravenous injection of non-
Fig. 8 Ultra high resolution (acquired voxel size: 0.4×0.4×0.4 mm3)
steady state CEMRA of the arterial palmar arch and the proximal
digital arteries, 45 s after injection of a blood pool agent. Although,
both arteries and veins are equally opacified during steady state and
separation of arteries and veins can be difficult, the arterial palmar
arch (arrowheads) can be identified as well as accompanying veins
(arrow)
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diluted contrast-media, and acquisition during delayed
venous enhancement after initial arterial first pass [59, 60].
Both techniques have their strengths and weaknesses.
Direct venography with application of a proximal blood
pressure cuff inflated to 60 mmHg yields better vessel
opacification with lower contrast dose compared with the
contralateral injection approach. Examples of a central
venous stenosis and obstruction by direct MR venography
are shown in Figs. 10 and 11.
Contrast-enhanced MR venography using delayed ve-
nous enhancement techniques showed relatively poor
performance for detection of central venous stenosis and
occlusions (sensitivity and specificity 50% and 80%) [61,
62]. Direct CE-MR venography is easy to perform, well
tolerated and highly accurate for detection of venous
stenosis and obstructions in the upper extremity and central
veins [59, 60, 63–65]. Furthermore, direct CE-MR venog-
raphy diameter measurements are more accurate compared
with duplex ultrasonography when using surgical measure-
ments as standard of reference [54]. Because of the lower
contrast dose, better vessel opacification and accuracy,
direct CE-MR venography seems to be the method of first
choice.
Although CE-MRA is a promising and attractive
modality for imaging the upper extremity arteries and
veins, there are only sparse data about the clinical value in
the work-up prior to vascular access creation. Future
studies are needed to determine the clinical significance of
adding CE-MRA to the preoperative work up prior to
vascular access creation.
Safety of gadolinium containing contrast agents
in patients with ESRD
The most widely used gadolinium chelates for CE-MRA
purposes are gadopentate dimeglumine (Magnevist; Schering,
Fig. 9 Typical example of a
subclavian artery stenosis, ini-
tially detected by CE-MRA (a)
and confirmed by DSA (b). The
arrow indicates the location of
the stenosis
Fig. 10 Example of a direct MR venogram of a patient with a
central venous stenosis. The arrowhead points at the venous outflow
stenosis
Fig. 11 Brachio-cephalic vein occlusion in a patient who had
multiple central venous catheters. The arrow points at the obstructed
brachio-cephalic vein in the direct CE-MR venogram. The arrow-
head indicates a draining collateral vein
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Berlin, Germany), gadoterate dimeglumine (Dotarem; Guer-
bet, Aulnay, France), gadodiamide (Omniscan; GE Health,
Oslo, Norway), gadoversetamide (OptiMARK; Mallinckrodt,
St Louis, Mo.) and gadoteridol (ProHance; Bracco Diagnos-
tics,Milan, Italy). The total incidence of adverse events related
to gadolinium use for CE-MRA appears to be less than 5%.
The incidence of any single adverse event is approximately
1%, or lower. By far the most common events are nausea,
headache, and emesis [43]. When used intravenously, no
detectable nephrotoxicity has been reported and the rates of
adverse events are extremely low at the doses used [66–68].
Recently, however, concerns have arisen regarding the
accumulation of free gadolinium in patients with renal failure
[43]. During the last decade approximately 200 cases of
nephrogenic systemic fibrosis (NSF), previously known as
nephrogenic fibrosing dermopathy, have been reported
worldwide [69, 70]. The reported clinical sings and symptoms
of NSF are subacute progressive swelling of extremities
followed by more proximal involvement and severe skin
induration, pain, muscle restlessness and loss of skin flexibil-
ity. NSF can lead to serious physical disability and wheelchair
requirement [70]. The incidence of NSF is low and the
pathophysiology is unknown [70]. To date, all gadolinium
chelates and gadodiamide (Omniscan) in particular, are
believed to be associated with NSF [71, 72]. Because of
these reported adverse events and the suspected causative
relationship, the use of gadolinium-containing contrast agents
should be discouraged in ESRD patients until the causative
relationship is proven untrue [71, 72].
Summary and conclusions
Although history taking and physical examination are
valuable in the pre-operative work-up of ESRD-patients
prior to hemodialysis access creation, according to current
guidelines, additional diagnostic modalities are indicated to
assess arterial and venous vessel quality, or in case of
suspected central venous obstruction.
The ultimate goal of preoperative assessment is to
prevent non-maturation by optimal selection of the site of
anastomosis and by identification and treatment of pre-
existing lesions before vascular access creation. However,
even with the use of available diagnostic tools, non-
maturation rates remain unacceptably high and standard-
ized protocols for preoperative DUS, DSA or CE-MRA are
lacking. Reported cut-off values for studied parameters are
inconsistent, which might be explained by differences
between research groups in measurement protocols and
differences in the parameters measured.
The phenomenon of non-maturation remains poorly
understood. To date, assessment of a single morphological
or functional parameter has not enabled adequate predic-
tion of postoperative AVF function for individual patients.
To further unravel causes of AVF non-maturation more
research is necessary. Furthermore, determination of
measurement reproducibility for each parameter and each
diagnostic modality is necessary before a standardized
preoperative diagnostic approach can be implemented.
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